Zonagen (zona) - good buy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bruce Rosen who wrote (654)	10/15/1997 10:19:00 PM
From: Cacaito	of 7041

Zona's patent is poor, Zona's patent is for the new use (new formulation is a simple pill, not DNA genetic science), but phentolamine have been off patent for long, this is a shaky patent tough to stop others. Of course, they can defend the product for a while (some chance). This is a valid point for the future, maybe not now that the strength of the stock is based on the hope of future FDA approval and/or a deal with another company. This are the types of "patents" that Barr succesfully fights (no problem for the inmediate future). Zonagen has a lot of cash after the secondary offering, fine they do not need the mexican sales to keep going. They used the news when they needed. I bought with the mexican trial news and sold with the american trials news (not entirely luck). Proceeds to vvus and did fine. Recent losses, no tears here, profits will be back. It is wrong to think that just because someone invest in Vivus one will not invest anywhere else in the ED market. Even if I have doubts about the vasomax and the FDA, it does not mean I could not be back in. Respectfully, cacaito.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next